Suppr超能文献

肝胰胆外科中作为静脉重建自体替代物的壁层腹膜

Parietal Peritoneum as an Autologous Substitute for Venous Reconstruction in Hepatopancreatobiliary Surgery.

作者信息

Dokmak Safi, Aussilhou Béatrice, Sauvanet Alain, Nagarajan Ganesh, Farges Olivier, Belghiti Jacques

机构信息

Department of HPB Surgery and Liver Transplantation, Beaujon Hospital, Clichy, France.

出版信息

Ann Surg. 2015 Aug;262(2):366-71. doi: 10.1097/SLA.0000000000000959.

Abstract

OBJECTIVE

To evaluate the parietal peritoneum (PP) as an autologous substitute for venous reconstruction during hepatopancreatobiliary (HPB) surgery.

BACKGROUND

Venous resection during liver or pancreatic resection may require a rapidly available substitute especially when the need for venous resection is unforeseen.

METHODS

The PP was used as an autologous substitute during complex liver and pancreatic resections. Postoperative anticoagulation was standard and venous patency was assessed by routine computed tomographic scans.

RESULTS

Thirty patients underwent vascular resection during pancreatic (n = 18) or liver (n = 12) resection, mainly for malignant tumors (n = 29). Venous resection was an emergency procedure in 4 patients due to prolonged vascular occlusion. The PP, with a mean length of 22 mm (15-70), was quickly harvested and used as a lateral (n = 28) or a tubular (n = 2) substitute for reconstruction of the mesentericoportal vein (n = 24), vena cava (n = 3), or hepatic vein (n = 3). Severe morbidity included Clavien grade-III complications in 4 (13%) patients but there was no PP-related or hemorrhagic complications. Histological vascular invasion was present in 18 (62%) patients, and all had an R0 resection (100%). After a mean follow-up of 14 (7-33) months, all venous reconstructions were patent except for 1 tubular graft (97%).

CONCLUSIONS

A PP can be safely used as a lateral patch for venous reconstruction during HPB surgery; this could help reduce reluctance to perform vascular resection when oncologically required. Clinical trials identification: NCT02121886.

摘要

目的

评估在肝胰胆(HPB)手术中,壁层腹膜(PP)作为静脉重建的自体替代物的效果。

背景

在肝脏或胰腺切除术中进行静脉切除时,可能需要一种能快速获取的替代物,尤其是在未预见需要进行静脉切除的情况下。

方法

在复杂的肝脏和胰腺切除术中,将PP用作自体替代物。术后抗凝治疗为标准治疗,通过常规计算机断层扫描评估静脉通畅情况。

结果

30例患者在胰腺(n = 18)或肝脏(n = 12)切除术中接受了血管切除,主要是因为恶性肿瘤(n = 29)。4例患者因血管长时间阻塞,静脉切除为急诊手术。平均长度为22毫米(15 - 70)的PP被快速获取,并用作侧方(n = 28)或管状(n = 2)替代物,用于重建肠系膜门静脉(n = 24)、腔静脉(n = 3)或肝静脉(n = 3)。严重并发症包括4例(13%)患者出现Clavien III级并发症,但没有与PP相关的或出血性并发症。18例(62%)患者存在组织学血管侵犯,且所有患者均实现了R0切除(100%)。平均随访14(7 - 33)个月后,除1例管状移植物外,所有静脉重建均保持通畅(97%)。

结论

在HPB手术中,PP可安全地用作静脉重建的侧方补片;这有助于减少在肿瘤学需要时对进行血管切除的顾虑。临床试验标识:NCT02121886。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验